Index RUT
P/E 2.42
EPS (ttm) 2.65
Insider Own 8.90%
Shs Outstand 161.96M
Perf Week -10.35%
Market Cap 1.04B
Forward P/E 28.25
EPS next Y 0.23
Insider Trans -0.10%
Shs Float 147.54M
Perf Month -16.54%
Enterprise Value 524.73M
PEG -
EPS next Q -0.06
Inst Own 56.77%
Short Float 30.30%
Perf Quarter -16.97%
Income 478.70M
P/S 0.83
EPS this Y 298.25%
Inst Trans -4.89%
Short Ratio 5.18
Perf Half Y -30.55%
Sales 1.25B
P/B -
EPS next Y -90.69%
ROA 36.18%
Short Interest 44.70M
Perf YTD -20.27%
Book/sh -0.47
P/C 1.40
EPS next 5Y -
ROE -
52W Range 5.01 - 17.81
Perf Year -54.38%
Cash/sh 4.58
P/FCF -
EPS past 3/5Y 62.54% 25.88%
ROIC 324.46%
52W High -64.01%
Perf 3Y -83.44%
Dividend Est. -
EV/EBITDA 1.12
Sales past 3/5Y -15.89% 105.39%
Gross Margin 87.18%
52W Low 27.94%
Perf 5Y -85.93%
Dividend TTM -
EV/Sales 0.42
EPS Y/Y TTM 198.04%
Oper. Margin 33.69%
Volatility 4.53% 3.49%
Perf 10Y -96.43%
Dividend Ex-Date Dec 13, 2007
Quick Ratio 2.03
Sales Y/Y TTM 25.92%
Profit Margin 38.14%
RSI (14) 42.11
Recom 2.71
Dividend Gr. 3/5Y - -
Current Ratio 2.06
EPS Q/Q 376.87%
SMA20 -9.28%
Beta 2.77
Target Price 13.43
Payout -
Debt/Eq -
Sales Q/Q 610.30%
SMA50 -4.44%
Rel Volume 0.56
Prev Close 6.30
Employees 952
LT Debt/Eq -
Earnings May 08 BMO
SMA200 -26.18%
Avg Volume 8.63M
Price 6.41
IPO Dec 05, 1995
Option/Short Yes / Yes
EPS/Sales Surpr. 792.18% 93.88%
Trades
Volume 4,815,114
Change 1.75%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-17-25 Initiated
Citigroup
Sell
$6
Feb-28-25 Initiated
BTIG Research
Buy
$19
Jul-30-24 Downgrade
JP Morgan
Neutral → Underweight
$8
May-10-24 Upgrade
JP Morgan
Underweight → Neutral
May-10-24 Upgrade
BofA Securities
Underperform → Neutral
$4 → $12
Aug-09-23 Upgrade
B. Riley Securities
Neutral → Buy
$15
Apr-20-23 Downgrade
TD Cowen
Outperform → Market Perform
$55 → $10
Mar-01-23 Downgrade
B. Riley Securities
Buy → Neutral
$29 → $10
Jan-09-23 Reiterated
B. Riley Securities
Buy
$74 → $37
Dec-30-22 Reiterated
H.C. Wainwright
Buy
$207 → $110
Dec-02-22 Initiated
Jefferies
Hold
Sep-22-22 Downgrade
JP Morgan
Neutral → Underweight
$132 → $27
May-20-22 Initiated
BofA Securities
Underperform
$35
Feb-23-22 Reiterated
B. Riley Securities
Buy
$315 → $265
Feb-22-22 Resumed
Jefferies
Buy
$198
Jan-21-22 Initiated
Cowen
Outperform
$150
May-12-21 Downgrade
JP Morgan
Overweight → Neutral
$285 → $161
Dec-14-20 Initiated
Jefferies
Buy
$200
Aug-06-20 Reiterated
H.C. Wainwright
Buy
$132 → $290
Aug-05-20 Upgrade
JP Morgan
Neutral → Overweight
$275
Show Previous Ratings
Jun-20-25 05:45PM
Jun-19-25 09:00AM
Jun-18-25 09:51AM
Jun-17-25 12:57PM
Jun-12-25 11:30AM
08:15AM
Loading…
08:15AM
Jun-11-25 10:20AM
10:20AM
09:50AM
07:11AM
07:11AM
07:00AM
Jun-10-25 04:10PM
(Investor's Business Daily)
10:10AM
Jun-09-25 06:07PM
(Investor's Business Daily)
09:00AM
Loading…
Jun-06-25 09:00AM
Jun-03-25 12:16PM
May-29-25 08:00AM
May-26-25 09:50AM
09:41AM
09:00AM
May-23-25 07:45AM
May-22-25 02:30PM
12:35PM
10:48AM
May-21-25 01:30PM
11:10AM
May-20-25 03:55PM
12:22PM
(Investor's Business Daily)
04:59AM
04:00AM
Loading…
04:00AM
May-19-25 05:18PM
04:30PM
03:44PM
03:42PM
11:55AM
10:46AM
10:30AM
09:43AM
(Associated Press Finance)
09:42AM
09:39AM
07:16AM
07:00AM
May-18-25 08:53PM
May-17-25 10:21PM
(Associated Press Finance)
May-13-25 09:00AM
May-09-25 09:50AM
08:55AM
03:13AM
May-08-25 01:55PM
01:31PM
12:15PM
09:15AM
08:14AM
(Associated Press Finance)
08:06AM
08:00AM
May-07-25 06:00PM
11:56AM
08:00AM
May-05-25 12:12PM
09:54AM
08:00AM
07:12AM
May-02-25 05:45PM
10:00AM
May-01-25 08:00AM
Apr-29-25 08:50AM
08:00AM
Apr-28-25 04:58PM
(Associated Press Finance)
02:21PM
01:50PM
11:38AM
09:04AM
08:45AM
08:16AM
Apr-25-25 03:20PM
(The Wall Street Journal) -5.66%
11:16AM
10:14AM
09:25AM
Apr-24-25 01:48AM
Apr-23-25 04:04PM
12:16PM
10:51AM
(Associated Press Finance)
09:25AM
09:00AM
08:56AM
Apr-22-25 10:39AM
06:00AM
Apr-21-25 05:45PM
07:36AM
Apr-17-25 10:51AM
Apr-15-25 05:45PM
07:00AM
Apr-11-25 11:33AM
11:20AM
09:00AM
08:39AM
Apr-10-25 04:18PM
(Yahoo Finance Video) -19.56%
03:02PM
01:23PM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MCGLYNN MARGARET G Director Jun 12 '25 Option Exercise 0.00 10,420 0 25,588 Jun 16 04:10 PM Alton Gregg H Director Jun 12 '25 Option Exercise 0.00 10,420 0 28,805 Jun 16 04:09 PM King Rachel K. Director Jun 12 '25 Option Exercise 0.00 10,420 0 25,190 Jun 13 09:41 PM Rodgers Richard J Director Jun 12 '25 Option Exercise 0.00 10,420 0 24,690 Jun 13 09:40 PM MOTT DAVID M Director Jun 12 '25 Option Exercise 0.00 10,420 0 60,890 Jun 13 09:39 PM DOUGLAS RICHARD Director Jun 12 '25 Option Exercise 0.00 10,420 0 54,340 Jun 13 09:36 PM YOUNG JAMES F Former Director May 19 '25 Proposed Sale 7.59 10,000 75,883 May 19 04:37 PM YOUNG JAMES F Former Director Apr 14 '25 Proposed Sale 6.10 4,000 24,406 Apr 14 04:19 PM Trizzino John President and COO Mar 07 '25 Option Exercise 0.00 28,890 0 82,015 Mar 11 04:34 PM Kelly James Patrick EVP, CFO and Treasurer Mar 07 '25 Option Exercise 0.00 12,223 0 75,155 Mar 11 04:33 PM Trizzino John President and COO Mar 01 '25 Option Exercise 0.00 48,000 0 76,310 Mar 04 06:47 PM Casey Mark J EVP, Chief Legal Officer Mar 01 '25 Option Exercise 0.00 4,000 0 33,187 Mar 04 06:46 PM Kelly James Patrick EVP, CFO and Treasurer Mar 01 '25 Option Exercise 0.00 58,667 0 91,269 Mar 04 06:43 PM Jacobs John C President and CEO Mar 01 '25 Option Exercise 0.00 83,334 0 175,183 Mar 04 06:42 PM O'Hara Elaine EVP, Chief Strategy Officer Mar 01 '25 Option Exercise 0.00 59,600 0 73,825 Mar 04 06:39 PM Jacobs John C President and CEO Jan 23 '25 Option Exercise 0.00 83,196 0 130,722 Jan 27 06:19 PM Kelly James Patrick EVP, CFO and Treasurer Dec 31 '24 Option Exercise 0.00 35,000 0 49,508 Jan 03 05:41 PM Rodgers Richard J Director Oct 29 '24 Option Exercise 0.00 3,800 0 14,270 Jan 02 04:52 PM King Rachel K. Director Dec 13 '24 Sale 9.02 4,150 37,435 14,770 Jan 02 04:47 PM YOUNG JAMES F Director Dec 31 '24 Sale 8.00 5,400 43,200 51,760 Jan 02 04:44 PM YOUNG JAMES F Director Dec 24 '24 Sale 8.48 4,600 39,008 57,160 Jan 02 04:44 PM YOUNG JAMES F Director Dec 24 '24 Proposed Sale 8.48 10,000 84,800 Dec 26 10:31 AM Casey Mark J EVP, Chief Legal Officer Dec 11 '24 Option Exercise 0.00 41,900 0 41,900 Dec 13 05:24 PM Rachel K. King Board Member Dec 13 '24 Proposed Sale 9.00 4,150 37,350 Dec 13 12:13 PM Dubovsky Filip Officer Sep 18 '24 Proposed Sale 13.00 7,335 95,331 Sep 18 04:08 PM Trizzino John EVP, CCO and CBO Aug 19 '24 Option Exercise 0.00 655 0 28,627 Aug 21 04:47 PM Kelly James Patrick EVP, CFO and Treasurer Aug 16 '24 Option Exercise 12.96 2,367 30,676 15,652 Aug 20 05:06 PM